The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tissue Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH)
The global Tissue Diagnostics market size is expected to reach US$ 6619.8 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories and Others,, are propelling Tissue Diagnostics market. Diagnostic Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Instruments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tissue Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tissue Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tissue Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tissue Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tissue Diagnostics covered in this report include Abbott, Agilent Technologies, Danaher, F. Hoffmann-La Roche, Sakura Finetek and Thermo Fisher Scientific, etc.
The global Tissue Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Sakura Finetek
Thermo Fisher Scientific
Global Tissue Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tissue Diagnostics market, Segment by Type:
Diagnostic Consumables
Diagnostic Instruments
Global Tissue Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tissue Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Tissue diagnostic procedures are majorly used for cancer diagnosis. Some of the major tissue diagnostic tests are immunochemistry (IHC), haematoxylin and eosin (H&E), and in situ hybridization (ISH)
The global Tissue Diagnostics market size is expected to reach US$ 6619.8 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories and Others,, are propelling Tissue Diagnostics market. Diagnostic Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Instruments segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tissue Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tissue Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tissue Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tissue Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tissue Diagnostics covered in this report include Abbott, Agilent Technologies, Danaher, F. Hoffmann-La Roche, Sakura Finetek and Thermo Fisher Scientific, etc.
The global Tissue Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Sakura Finetek
Thermo Fisher Scientific
Global Tissue Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tissue Diagnostics market, Segment by Type:
Diagnostic Consumables
Diagnostic Instruments
Global Tissue Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tissue Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Tissue Diagnostics
1.1 Tissue Diagnostics Market Overview
1.1.1 Tissue Diagnostics Product Scope
1.1.2 Tissue Diagnostics Market Status and Outlook
1.2 Global Tissue Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tissue Diagnostics Market Size by Region (2018-2029)
1.4 Global Tissue Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Tissue Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tissue Diagnostics Market Size (2018-2029)
1.6.1 North America Tissue Diagnostics Market Size (2018-2029)
1.6.2 Europe Tissue Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Tissue Diagnostics Market Size (2018-2029)
1.6.4 Latin America Tissue Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Tissue Diagnostics Market Size (2018-2029)
2 Tissue Diagnostics Market by Type
2.1 Introduction
2.1.1 Diagnostic Consumables
2.1.2 Diagnostic Instruments
2.2 Global Tissue Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tissue Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Tissue Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tissue Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tissue Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tissue Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tissue Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tissue Diagnostics Revenue Breakdown by Type (2018-2029)
3 Tissue Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Others
3.2 Global Tissue Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tissue Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Tissue Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tissue Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tissue Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tissue Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tissue Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tissue Diagnostics Revenue Breakdown by Application (2018-2029)
4 Tissue Diagnostics Competition Analysis by Players
4.1 Global Tissue Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tissue Diagnostics as of 2022)
4.3 Date of Key Players Enter into Tissue Diagnostics Market
4.4 Global Top Players Tissue Diagnostics Headquarters and Area Served
4.5 Key Players Tissue Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Tissue Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Tissue Diagnostics Products, Services and Solutions
5.1.4 Abbott Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Agilent Technologies
5.2.1 Agilent Technologies Profile
5.2.2 Agilent Technologies Main Business
5.2.3 Agilent Technologies Tissue Diagnostics Products, Services and Solutions
5.2.4 Agilent Technologies Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Agilent Technologies Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Tissue Diagnostics Products, Services and Solutions
5.3.4 Danaher Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 F. Hoffmann-La Roche Recent Developments
5.4 F. Hoffmann-La Roche
5.4.1 F. Hoffmann-La Roche Profile
5.4.2 F. Hoffmann-La Roche Main Business
5.4.3 F. Hoffmann-La Roche Tissue Diagnostics Products, Services and Solutions
5.4.4 F. Hoffmann-La Roche Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 F. Hoffmann-La Roche Recent Developments
5.5 Sakura Finetek
5.5.1 Sakura Finetek Profile
5.5.2 Sakura Finetek Main Business
5.5.3 Sakura Finetek Tissue Diagnostics Products, Services and Solutions
5.5.4 Sakura Finetek Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Sakura Finetek Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Tissue Diagnostics Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Tissue Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Tissue Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tissue Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tissue Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tissue Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tissue Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tissue Diagnostics Market Dynamics
11.1 Tissue Diagnostics Industry Trends
11.2 Tissue Diagnostics Market Drivers
11.3 Tissue Diagnostics Market Challenges
11.4 Tissue Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
